Newsroom

Biomarker Testing FDA Approval Press Release Research

New FDA Approval Expands Targeted Treatment Options for HER2-Mutated Lung Cancer

Biomarker Testing Provider Education Research Rural

Rural Minnesota Lung Cancer Summit

Research

Research Participation Opportunity

Advocacy Clinical Trials Newsletter Research

ASCO 2026: Hope, Innovation, and the Power of Connection

Advocacy Lung Cancer Story

Honoring Our Founding Day

Research

Research Update | Project Title: BiTE to target EGFR peptide: HLA class I complexes in EGFR mutant lung cancers

Research

Research Update | Project Title: Exploring Differences in Immunotherapy Response in EGFR and KRAS-mutated Lung Cancer

Research

Research Update | Project Title: miR-29 as a Master Regulator of Anti-Tumor Immunity